Evolus (EOLS) Operating Margin (2019 - 2026)

Evolus (EOLS) posted Operating Margin of 9.36% for Q1 2026, down 300.36% on a QoQ basis from 4.67% in Q4 2025, and up 1278.0% year-over-year from 0.68% in Q1 2025.

Evolus (EOLS) Operating Margin (2019 - 2026) Analysis & Trends

Evolus' Operating Margin history runs 8 years deep, the most recent figure standing at 9.36% for Q1 2026.

  • Quarterly Operating Margin rose 1278.0% year-over-year to 9.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.06% (up 670.0% YoY) and the FY2025 annual result came in at 10.99%, up 193.0% from the prior year.
  • Operating Margin was 9.36% for Q1 2026 at Evolus, down from 4.67% in the prior quarter.
  • Across five years, Operating Margin topped out at 4.67% in Q4 2025 and bottomed at 57.44% in Q2 2022.
  • A 5-year average of 23.16% and a median of 22.14% in 2025 frame the typical range for Operating Margin.
  • Peak annual rise in Operating Margin reached 2765 bps in 2022, while the deepest fall reached 11113 bps in 2022.
  • Evolus' Operating Margin stood at 24.37% in 2022, then jumped by 42 bps to 14.16% in 2023, then soared by 79 bps to 2.93% in 2024, then soared by 259 bps to 4.67% in 2025, then tumbled by 300 bps to 9.36% in 2026.
  • Business Quant data shows EOLS's Operating Margin at 9.36% in Q1 2026, 4.67% in Q4 2025, and 16.67% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -9.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.36%
Dec 31, 2025 4.67%
Sep 30, 2025 -16.67%
Jun 30, 2025 -14.71%
Mar 31, 2025 -22.14%
Dec 31, 2024 -2.93%
Sep 30, 2024 -25.33%
Jun 30, 2024 -11.51%
Mar 31, 2024 -15.04%
Dec 31, 2023 -14.16%
Sep 30, 2023 -26.87%
Jun 30, 2023 -30.64%
Mar 31, 2023 -28.86%
Dec 31, 2022 -24.37%
Sep 30, 2022 -52.80%
Jun 30, 2022 -57.44%
Mar 31, 2022 -45.56%
Dec 31, 2021 -52.02%
Sep 30, 2021 -71.63%
Jun 30, 2021 -58.60%